Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02470312 · ClinicalTrials.gov registry record
MediGuide Registry
A clinical trial, sponsored by Abbott Medical Devices.
- Terminated
- Registry status
- 578
- Enrollment target
NCT02470312 is a clinical trial that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 578 participants.
The verdict
NCT02470312 was terminated before completion, sponsored by Abbott Medical Devices.
- TERMINATED
- Registry status
- 578 participants
- Enrollment target
Study Summary
The goal of this registry/observational study is to collect data on the clinical utility of MediGuide™ system in cardiac resynchronization therapy (CRT) implantation and electrophysiology (EP) procedures.
Interventions
- PROCEDURE CRT implantation
- DEVICE MediGuide
- PROCEDURE EP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 578 participants |
| Start Date | 2015-08-18 |
| Est. Completion | 2018-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02470312
The ClinicalTrials.gov registry entry for NCT02470312 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 578 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which CRT implantation is the first listed.
NCT02470312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02470312 about?
NCT02470312 is a clinical study titled "MediGuide Registry". The goal of this registry/observational study is to collect data on the clinical utility of MediGuide™ system in cardiac resynchronization therapy (CRT) implantation and electrophysiology (EP) procedures.
What is the current status of trial NCT02470312?
This trial is currently terminated. The enrollment target is 578 participants. The study started on 2015-08-18. Estimated completion is 2018-02-28.
What interventions are being tested in trial NCT02470312?
The interventions under investigation include: CRT implantation (PROCEDURE), MediGuide (DEVICE), EP (PROCEDURE).
Who is sponsoring clinical trial NCT02470312?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.